360 NEWS360 NEWS

Business ยท National

No FOMO, Sanofi India looks to strengthen presence in rare disease, diabetes and haemophilia segments, says MD

Over the last 70 years, he said, about 200 trials have been done at 400-odd sites, and presently 18 are underway in future products in segments

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on โ€œNo FOMO, Sanofi India looks to strengthen presence in rare disease, diabetes and haemophilia segments, says MDโ€?

This is self-selected reader participation, not representative scientific polling.